Search

everythinglearnresearchcommunity

for

Search:↓

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Flexible bioelectronics show promise in non-invasive cancer detection and treatment but need improvements in stability and effectiveness.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Targeted cancer therapies often cause serious skin problems that need careful management.

Cell membrane-coated nanoparticles could improve gene therapy by enhancing delivery and targeting of nucleic acids.

Anthocyanins from fruits and vegetables may help prevent and treat colorectal cancer safely.

Protein Kinase Cε increases skin sensitivity to UV damage and skin cancer risk.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

Hederagenin shows promise for cancer and inflammation treatment but needs modifications to improve effectiveness.

SLCO genes may predict prostate cancer mortality risk, and lifestyle changes improve health in advanced prostate cancer.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Certain cancer drugs can cause skin issues like rashes and itching.

Curcuma longa and Dalbergia sissoo may work well together to treat inflammation, stress, and cancer.

Plant-derived extracellular vesicles show promise for treating diseases like cancer and inflammation.

Some hormone treatments might raise breast cancer risk, while others don't seem to.